Phoenix Biotech Acquisition Corp.
2201 Broadway, Suite 705
Oakland, CA 94612
October 1, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Energy & Transportation
100 F Street, N. E.
Washington, D.C. 20549
Re: | Phoenix Biotech Acquisition Corp. |
Registration Statement on Form S-1
Filed September 13, 2021, as amended
File No. 333-259491
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Phoenix Biotech Acquisition Corp. (the “Registrant”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00PM EST on October 5, 2021, or as soon as practicable thereafter.
Very truly yours, |
/s/ Chris Ehrlich |
Chris Ehrlich Chief Executive Officer |
cc: | Ellenoff Grossman & Schole LLP |
Ledgewood, PC |